Shift Bioscience has built the best-in-class target discovery platform for cell rejuvenation, identifying an initial siRNA program in liver fibrosis with first-in-class and expansion potential. Cambridge (UK) based with a team spanning Longevity, virtual cells, siRNA and liver disease, Shift is seeking strategic partnerships that accelerate the first medicines for both healthspan and lifespan.
| Website | https://shiftbioscience.com |
| Revenue | $3 million |
| Employees | 24 (15 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript
,
HTML
,
Microsoft Outlook
+8 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Life Extension, Cellular Reprogramming, Aging Reversal, Molecular Biology, High Throughput, Cellular Therapy, Regenerative Medicine, Anti Aging, Longevity Research, Biotechnology, Drug Discovery, Bioscience, Clinical Research, In Vitro |
| Competitors | Calico Life Sciences, Synthego Corporation, UNITY Biotechnology, Elysium Health, Insilico Medicine, LyGenesis, Life Biosciences, Geroscience, Rejuveron Telomere Therapeutics +25 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies |
Looking for a particular Shift Bioscience employee's phone or email?
The Shift Bioscience annual revenue was $3 million in 2026.
Andrew Armour is the CFO of Shift Bioscience.
15 people are employed at Shift Bioscience.
The NAICS codes for Shift Bioscience are [54, 541, 5417, 54171, 541714].
The SIC codes for Shift Bioscience are [87, 873].